bioAffinity Technologies (BIAF) Preferred Stock Liabilities (2021)
bioAffinity Technologies (BIAF) posted quarterly Preferred Stock Liabilities of $4.0 million for Q4 2021.
bioAffinity Technologies (BIAF) Preferred Stock Liabilities (2021) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Preferred Stock Liabilities for 1 consecutive years, with $4.0 million the latest figure, recorded in Q4 2021.
- In Q4 2021, Preferred Stock Liabilities changed N/A year-over-year to $4.0 million; the TTM figure through Dec 2021 stood at $4.0 million (changed N/A YoY), while the FY2021 annual figure was $4.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities steadied at $4.0 million in Q4 2021 per BIAF's latest filing.
- Across five years, Preferred Stock Liabilities topped out at $4.0 million in Q4 2021 and bottomed at $4.0 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 4.04 Mn |